Research Organization Profiles

Cirrus Pharmaceuticals, Inc., Research Triangle Park, NC

Cirrus Pharmaceuticals, Inc. is a contract product development company assisting biotechnology and pharmaceutical companies with dosage form development projects. It applies advanced scientific knowledge and technological expertise to develop safe, effective and robust products. Within its first eight years of operation, Cirrus was able to bring a product from concept to NDA approval. It's scientific and product development expertise in inhalation products and protein formulations has already generated several patent filings for its clients.

Cirrus works with Quigley Pharma on QR-333 and QR-435.

 

MDBiosciences, Ltd., St. Paul, Minn., Zurich, Switzerland, Nes Ziona, Israel

MD Biosciences provides products and pre-clinical services for pharmaceutical and biotechnology companies engaged in inflammations and neurology research. The company is headquartered in Switzerland under Morwell Diagnostics and has specialized laboratories located in Minnesota, Glasgow, and Israel. A panel of internationally recognized scientific experts provides in-depth expertise and technologies to provide customized drug discovery solutions. Among the service offerings are traditional disease models as well as ImmuneProfiler> (tm)>  for profiling anti-inflammatory activities and Senerga® Mode of Action Program for determining a compounds mechanism of action.

MDBiosciences works with Quigley Pharma on its novel compound for the treatment of arthritis.

 

Chemir Analytical Services

Chemir Analytical Services solves difficult product development problems for numerous industries with its analytical, deformulation (reverse engineering), materials identification, product failure analysis, competitive product analysis, litigation support and consulting services. Its Ph.D. chemists supervise state-of-the-art analytical testing for pharmaceutical testing, chemical analysis, plastic testing, metals testing and polymer analysis. It also supports its clients with custom synthesis services and extractable/ leachable testing.

Chemir works with Quigley Pharma on QR-333.

 

Biologics Consulting Group, Inc.,

The Biologics Consulting Group specializes in the preparation and review of CDER and CBER regulatory applications (INDs and NDAs/BLAs) as well as the inspection/audit of manufacturing facilities. Because of our familiarity with CDER and CBER expectations we have an excellent reputation for filing high-quality, easily reviewable applications.

Biologics works with Quigley Pharma on QR-333.

 

Research and  Development Disclaimer

The Quigley Corporation makes no representation that the US Food and Drug Administration or any other regulatory agency will grant an Investigational New Drug ("IND") or take any other action to allow its formulations to be studied or/and for any Investigational New Drug to be marketed. Furthermore, no claim is made that potential medicine discussed herein is safe, effective, or approved by the Food and Drug Administration. Additionally, data that demonstrates activity or effectiveness in animals or in vitro tests do not necessarily mean the formula test compound, referenced herein will be effective in humans. Safety and effectiveness in humans will have to be demonstrated by means of adequate and well controlled clinical studies before the clinical significance of the formula test compound is known. Readers should carefully review the risk factors described in filings the Company files from time to time with the Securities and Exchange Commission.